146 related articles for article (PubMed ID: 7875745)
1. Effect of IFN-gamma on the proliferation of Toxoplasma gondii in monocytes and monocyte-derived macrophages from AIDS patients.
Delemarre FG; Stevenhagen A; Kroon FP; van Eer MY; Meenhorst PL; van Furth R
Immunology; 1994 Dec; 83(4):646-50. PubMed ID: 7875745
[TBL] [Abstract][Full Text] [Related]
2. Reduced toxoplasmastatic activity of monocytes and monocyte-derived macrophages from AIDS patients is mediated via prostaglandin E2.
Delemarre FG; Stevenhagen A; Kroon FP; van Eer MY; Meenhorst PL; van Furth R
AIDS; 1995 May; 9(5):441-5. PubMed ID: 7639969
[TBL] [Abstract][Full Text] [Related]
3. In vitro and in vivo activation of human mononuclear phagocytes by interferon-gamma. Studies with normal and AIDS monocytes.
Murray HW; Scavuzzo D; Jacobs JL; Kaplan MH; Libby DM; Schindler J; Roberts RB
J Immunol; 1987 Apr; 138(8):2457-62. PubMed ID: 3104467
[TBL] [Abstract][Full Text] [Related]
4. Human mononuclear phagocyte antiprotozoal mechanisms: oxygen-dependent vs oxygen-independent activity against intracellular Toxoplasma gondii.
Murray HW; Rubin BY; Carriero SM; Harris AM; Jaffee EA
J Immunol; 1985 Mar; 134(3):1982-8. PubMed ID: 2981929
[TBL] [Abstract][Full Text] [Related]
5. Activation of tissue macrophages from AIDS patients: in vitro response of AIDS alveolar macrophages to lymphokines and interferon-gamma.
Murray HW; Gellene RA; Libby DM; Rothermel CD; Rubin BY
J Immunol; 1985 Oct; 135(4):2374-7. PubMed ID: 3928746
[TBL] [Abstract][Full Text] [Related]
6. Microbicidal activity of monocyte derived macrophages in AIDS and related disorders.
Eales LJ; Moshtael O; Pinching AJ
Clin Exp Immunol; 1987 Feb; 67(2):227-35. PubMed ID: 3111759
[TBL] [Abstract][Full Text] [Related]
7. Activation of mouse peritoneal macrophages in vitro and in vivo by interferon-gamma.
Murray HW; Spitalny GL; Nathan CF
J Immunol; 1985 Mar; 134(3):1619-22. PubMed ID: 3918107
[TBL] [Abstract][Full Text] [Related]
8. CD40-CD40 ligand interaction is central to cell-mediated immunity against Toxoplasma gondii: patients with hyper IgM syndrome have a defective type 1 immune response that can be restored by soluble CD40 ligand trimer.
Subauste CS; Wessendarp M; Sorensen RU; Leiva LE
J Immunol; 1999 Jun; 162(11):6690-700. PubMed ID: 10352287
[TBL] [Abstract][Full Text] [Related]
9. Reduced toxoplasmastatic activity of monocytes from AIDS patients: a role for granulocyte-macrophage colony-stimulating factor.
Delemarre FG; Stevenhagen A; Kroon FP; van Furth R
Scand J Immunol; 1998 Feb; 47(2):163-6. PubMed ID: 9496693
[TBL] [Abstract][Full Text] [Related]
10. Tumor necrosis factor-independent protective effect of recombinant IFN-gamma against acute toxoplasmosis in T cell-deficient mice.
Suzuki Y; Joh K; Kobayashi A
J Immunol; 1991 Oct; 147(8):2728-33. PubMed ID: 1918987
[TBL] [Abstract][Full Text] [Related]
11. In vivo and in vitro activation of alveolar macrophages by recombinant interferon-gamma.
Black CM; Catterall JR; Remington JS
J Immunol; 1987 Jan; 138(2):491-5. PubMed ID: 3098846
[TBL] [Abstract][Full Text] [Related]
12. HIV-1 infection of human macrophages impairs phagocytosis and killing of Toxoplasma gondii.
Biggs BA; Hewish M; Kent S; Hayes K; Crowe SM
J Immunol; 1995 Jun; 154(11):6132-9. PubMed ID: 7751654
[TBL] [Abstract][Full Text] [Related]
13. Interferon-gamma corrects the respiratory burst defect in vitro in monocyte-derived macrophages from glycogen storage disease type 1b patients.
McCawley LJ; Korchak HM; Cutilli JR; Stanley CA; Baker L; Douglas SD; Kilpatrick L
Pediatr Res; 1993 Sep; 34(3):265-9. PubMed ID: 8134165
[TBL] [Abstract][Full Text] [Related]
14. Effect of recombinant interferon-gamma on hydrogen peroxide-releasing capacity of monocyte-derived macrophages from patients with lepromatous leprosy.
Kaplan G; Nathan CF; Gandhi R; Horwitz MA; Levis WR; Cohn ZA
J Immunol; 1986 Aug; 137(3):983-7. PubMed ID: 3088117
[TBL] [Abstract][Full Text] [Related]
15. Effect of recombinant interferon gamma administration on lesional monocytes/macrophages in lepromatous leprosy patients.
SivaSai KS; Prasad HK; Misra RS; Ramesh V; Wilfred D; Nath I
Int J Lepr Other Mycobact Dis; 1993 Jun; 61(2):259-69. PubMed ID: 8396615
[TBL] [Abstract][Full Text] [Related]
16. In vitro studies on the influence of doxorubicin in combination with recombinant interferon-gamma on human monocytes.
Van Schie RC; De Mulder PH; Verstraten HG; Van Rennes H; Wagener DJ
Anticancer Res; 1991; 11(3):1245-52. PubMed ID: 1832272
[TBL] [Abstract][Full Text] [Related]
17. Effect of rIFN-gamma and IL-2 treatments in mouse and nude rat infections with Toxoplasma gondii.
Benedetto N; Auriault C; Darcy F; Lando D; Watier H; Capron A
Eur Cytokine Netw; 1991; 2(2):107-14. PubMed ID: 1813013
[TBL] [Abstract][Full Text] [Related]
18. HIV-1 transmission and cytokine-induced expression of DC-SIGN in human monocyte-derived macrophages.
Chehimi J; Luo Q; Azzoni L; Shawver L; Ngoubilly N; June R; Jerandi G; Farabaugh M; Montaner LJ
J Leukoc Biol; 2003 Nov; 74(5):757-63. PubMed ID: 12960240
[TBL] [Abstract][Full Text] [Related]
19. Cytokine regulation of human monocyte differentiation in vitro: the tumor-cytotoxic phenotype induced by macrophage colony-stimulating factor is developmentally regulated by gamma-interferon.
Munn DH; Armstrong E
Cancer Res; 1993 Jun; 53(11):2603-13. PubMed ID: 8495423
[TBL] [Abstract][Full Text] [Related]
20. Characterization of small and large human peripheral blood monocytes: effects of in vitro maturation on hydrogen peroxide release and on the response to macrophage activators.
Turpin J; Hersh EM; Lopez-Berestein G
J Immunol; 1986 Jun; 136(11):4194-8. PubMed ID: 3084656
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
